1.07
Canopy Growth Corporation stock is traded at $1.07, with a volume of 13.61M.
It is down -1.83% in the last 24 hours and down -13.01% over the past month.
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
13.61M
Relative Volume:
0.48
Market Cap:
$404.31M
Revenue:
$199.32M
Net Income/Loss:
$-272.74M
P/E Ratio:
-0.5489
EPS:
-1.9494
Net Cash Flow:
$-63.86M
1W Performance:
-7.76%
1M Performance:
-13.01%
6M Performance:
-32.28%
1Y Performance:
-40.88%
Canopy Growth Corporation Stock (CGC) Company Profile
Name
Canopy Growth Corporation
Sector
Phone
855-558-9333
Address
1 Hershey Drive, Smiths Falls, ON
Compare CGC vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CGC
Canopy Growth Corporation
|
1.07 | 411.87M | 199.32M | -272.74M | -63.86M | -1.9494 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Apr-04-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Nov-02-22 | Initiated | Bernstein | Underperform |
| Oct-26-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-08-22 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Mar-22-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-22-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-20-21 | Downgrade | Piper Sandler | Neutral → Underweight |
| Dec-07-21 | Initiated | Wells Fargo | Underweight |
| Nov-18-21 | Initiated | Barclays | Equal Weight |
| Nov-08-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Nov-08-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Nov-08-21 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-01-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-21 | Upgrade | Jefferies | Underperform → Hold |
| Jun-02-21 | Upgrade | Canaccord Genuity | Sell → Hold |
| May-25-21 | Upgrade | MKM Partners | Neutral → Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-24-21 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| Feb-10-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-05-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-04-20 | Upgrade | CFRA | Buy → Strong Buy |
| Jun-01-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jun-01-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Jun-01-20 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-01-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-01-20 | Downgrade | Stifel | Buy → Sell |
| May-22-20 | Resumed | BofA/Merrill | Buy |
| Apr-16-20 | Upgrade | Jefferies | Underperform → Hold |
| Jan-28-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Dec-12-19 | Reiterated | Cantor Fitzgerald | Neutral |
| Nov-20-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-15-19 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-14-19 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Oct-11-19 | Downgrade | Jefferies | Hold → Underperform |
| Sep-27-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Sep-18-19 | Initiated | Oppenheimer | Perform |
| Aug-26-19 | Upgrade | Seaport Global Securities | Neutral → Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Buy |
View All
Canopy Growth Corporation Stock (CGC) Latest News
Should Canopy Growth stock be in your portfolio post Q3 earnings? - MSN
Should Canopy Growth Stock Be in Your Portfolio Post Q3 Earnings? - The Globe and Mail
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Canopy Growth Corporation Postpones Annual General and Special Shareholders Meeting Due to Insufficient Quorum - Intellectia AI
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
MTL Cannabis Reminds MTL Shareholders to Vote FOR the Arrangement Resolution to Approve the Proposed Plan of Arrangement with Canopy Growth at the Upcoming Special Meeting of MTL Shareholders - Newswire Canada
Canopy Growth Reports Substantial Loss Reduction in Q3 Earnings - AD HOC NEWS
(WEED) Proactive Strategies (WEED:CA) - Stock Traders Daily
Canopy Growth Reports Mixed Quarterly Results and Strategic Acquisition - AD HOC NEWS
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Canopy Growth’s Mixed Quarter: Losses Narrow but Earnings Miss - AD HOC NEWS
Canopy Growth Reports Sharply Narrowed Losses in Q3 - AD HOC NEWS
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Canopy Growth’s Narrowing Losses Met With Analyst Skepticism - AD HOC NEWS
Canopy Growth (TSX:WEED) Valuation Check After Narrowed Losses And New Shelf Registration - Yahoo Finance
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Canopy Growth signals positive adjusted EBITDA in fiscal 2027 amid MTL acquisition and expanding European focus - MSN
Is It Time to Dump Your Shares of Canopy Growth Corp? - Yahoo Finance
Canopy Growth Corporation (NASDAQ:CGC) Q3 2026 Earnings Call Transcript - Insider Monkey
When (WEED) Moves Investors should Listen (WEED:CA) - Stock Traders Daily
Wall Street Zen Downgrades Canopy Growth (NASDAQ:CGC) to Sell - MarketBeat
Canopy Growth Narrows Losses Amid Strategic Restructuring - AD HOC NEWS
Canopy Growth Q3 2026 Earnings Call Transcript - MarketBeat
Canopy Growth (CGC) Announces Sale of 18.71 Million Common Shares - GuruFocus
Canopy Growth Q3 Earnings Call Highlights - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Canopy Growth Corp (CGC) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges in ... By GuruFocus - Investing.com Canada
Canopy Growth (NASDAQ:CGC) Posts Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
Canopy Growth Corp (TSX:WEED) Shifts Focus While Tracking TSX Smallcap Index Today - Kalkine Media
Canopy’s domestic sales increase in Q3 2026 while international sales decline - StratCann
Earnings call transcript: Canopy Growth Q3 2026 misses EPS, beats revenue - Investing.com
WEED: Revenue growth, cost savings, and MTL acquisition position for positive EBITDA in 2027 - TradingView
WEED: Q3 delivered revenue growth, improved margins, and a stronger balance sheet, with MTL acquisition ahead - TradingView
Canopy Growth Reports Narrowed Losses Amid Strategic Overhaul - AD HOC NEWS
Stocks in play: Canopy Growth Corporation - Barchart.com
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Canopy Growth posts mixed Q3 results, narrower loss amid ongoing cost cuts - Proactive financial news
Canopy Growth reports Q3 EPS (C$0.18) vs. (C$1.11) last year - TipRanks
Canopy Growth (CGC) Q3 FY2026 earnings: loss narrows by 49% - grafa.com
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Canopy Growth Narrows Losses and Bolsters Balance Sheet as Canadian Cannabis Sales Rise - TipRanks
Canopy Growth Q3 Net Loss Narrows - marketscreener.com
Canopy Growth posts Q3 FY26 results (CGC:NASDAQ) - Seeking Alpha
Canopy Growth Brief: Citing $371M in Cash and Cash Equivalents With a Net Cash Position of $146M at Dec. 31, 2025 - marketscreener.com
Canopy Growth Brief: Basic and Diluted Loss Per Share $0.18 - marketscreener.com
Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results - The Globe and Mail
WEED: Net loss narrowed 49% year-over-year as Canadian cannabis revenue grew and cost savings took hold - TradingView
Canopy Growth Q3 revenue beats estimates driven by insured patients, larger orders - TradingView
Canopy Growth (CGC) Misses Q3 EPS by 14c - StreetInsider
Canopy Growth Corp SEC 10-Q Report - TradingView
Canopy Growth Corporation Stock (CGC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):